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Abstract
Background: Epidural fibrosis often causes serious complications in patients after lumbar laminectomy and
discectomy and is associated with the proliferation of fibroblasts. Suramin is known to have an obvious inhibitory
effect on the coactions of many growth factors and their receptors, but little was previously known about the effect
of suramin on fibroblast proliferation and the progress of epidural fibrosis.
Methods: We illustrated the effect of suramin on cultured fibroblasts of rats with different concentrations
(0, 200, 400, 600 mg/l). The proliferation of suramin-treated fibroblasts was evaluated by CCK-8 and western blot
analysis. Additionally, in a rat model of laminectomy, different concentrations of suramin (100, 200, and 300 mg/ml)
and saline were applied to the laminectomy sites locally. The effect of suramin on preventing epidural fibrosis was
detected by the Rydell classification, hydroxyproline content, histological analysis, and collagen density analyses.
Results: The results of CCK-8 shown that suramin could significantly inhibit fibroblasts proliferation in a
dose-dependent manner. The western blotting shown that the expression levels of the cell proliferation markers
such as cyclin D1, cyclin E, and PCNA were down-regulated. Moreover, in a rat model, we found that suramin could
reduce epidural fibrosis as well as inhibit fibroblast proliferation, and 300 mg/ml suramin had better effect.
Conclusions: Topical application of suramin could reduce epidural fibrosis after laminectomy, and the application
of suramin could inhibit the proliferation of fibroblasts in rats. This study indicates that suramin is a potent
antifibrotic agent that may have therapeutic potential for patients with epidural fibrosis.
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Background
Epidural fibrosis following lumbar laminectomy and
discectomy is a common outcome and remains a chal-
lenging clinical problem for surgeons [1, 2]. It may result
in unfavorable clinical outcome and contribute to more
complications in revision spine surgery, such as dural
tears, nerve root injury, and bleeding. Although the
definite mechanism of fibrosis formation is still unclear,
some reports have shown that fibroblast proliferation
and the succeeding release of extracellular matrix were
the main reasons for epidural fibrosis [3].
At present, the process of epidural fibrosis cannot be
effectively prevented. In order to control epidural fibrosis,
many therapeutic strategies have been sought to reduce
tissue damage and avoid adverse complication [4, 5]. For
example, various agents or mechanical barriers have been
used to prevent epidural fibrosis both in animal models
and humans, including Adcon-L, autologous fat grafts,
fibrinolytic agents, and polytetrafluoroethylene membrane
[6–8]. However, all of these techniques are not without
complications.
Suramin, a polyanionic drug, specifically inhibits many
growth factors. In clinical practice, suramin has been com-
monly used to treat trypanosomiasis and onchocerciasis by
inhibiting DNA polymerases and reverse transcriptase [9].
Recently, suramin has been demonstrated to be effective in
reducing peritoneal fibrosis [10], chronic renal fibrosis [11],
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and the fibrosis of proliferative eye disease [12]. Also, it
was found that suramin could inhibit cell proliferation
[13–15], which implicated that suramin might be useful in
prevention of epidural fibrosis through inhibiting the pro-
liferation of fibroblasts.
Therefore, we designed the study to explore the possible
preventive effect of local application of suramin in pre-
venting and reducing epidural fibrosis in rats after lamin-
ectomy. Additionally, we investigated suramin’s effects on
fibroblast proliferation in vitro at different concentrations.
Our results may be helpful for future human trials and
clinical applications for treating epidural fibrosis.
Methods
Cell culture and treatment
A primary fibroblast cell line was established from
epidural scar tissue isolated from rats that underwent
laminectomies 4 weeks later [16]. Fibroblasts were
grown in Dulbecco’s modified Eagle’s medium (DMEM;
Gibco, Grand Island, NY) with 15 % fetal bovine serum,
0.1 U/l penicillin, and 50 μg/ml streptomycin (PS;
Thermo, Rockford, IL) at 37 °C in 5 % CO2. Medium
was changed every 3 days. Cells between passages 4 and
7 were used for all experiments. After reaching approxi-
mately 60–70 % confluence, the cells were cultured in
fresh medium without fetal bovine serum overnight and
then treated with suramin of different concentrations
and combinations of all substances.
Cell viability
Cell Counting Kit-8 (CCK-8; Dojindo, Tokyo, Japan) was
used to detect the cell viability. Fibroblasts at passages 4
and 7 were seeded in four replicates in 96-well plates
(100 ml, 2 × 103/well) overnight. Then, fibroblasts were
treated with suramin of different concentrations (0, 200,
400, 600 mg/l). Forty-eight hours later, the cells were
further incubated with 10 μl CCK-8 solution for 2 h.
Cells that stained positively with CCK-8 were considered
viable. Cell survival rate was calculated according to the
reference manual.
Western blotting analyses
After received various treatments, the fibroblasts were col-
lected. In order to carry out western blot analysis, the cells
should be first treated with RIPA buffer on ice. Following
sonicated and centrifuged in sequence, the proteins were
collected for western blot analysis. BCA Protein Assay Kit
was used to measure protein concentrations. The proteins
were separated on a 6–12 % SDS-polyacrylamide gel elec-
trophoresis and then transferred for 1.5 h at 200 mA to
polyvinylidene difluoride membranes (Millipore, Bedford,
MA) on ice. Then the PVDF membranes were blocked
with 5 % skimmed milk in tris-buffered saline and Tween
20 for 2 h at room temperature and incubated with
primary antibodies at 4 °C overnight. The primary anti-
bodies were anti-cyclinD1, anti-cyclinE, anti- polyclonal
proliferating cell nuclear antigen (PCNA), and anti-β-actin
antibodies (Cell Signaling Technology, USA). Next day,
after washing, the membranes were incubated with anti-
rabbit/mouse antibodies (Cell Signaling Technology,
USA) for 1.5 h at room temperature. Then, we washed the
membranes for three times. At last, the membranes were
exposed using the ECL system (Millipore, Bedford, USA).
Animals
This study uses 48 adult, healthy, Sprague-Dawley rats. All
these white rats, whose mean weight was 260 g, were
purchased from Yangzhou Laboratory Animal Center,
Yangzhou, China. All animals received care in accordance
with the principles of Laboratory Animal Care of inter-
national recommendation. 48 healthy rats and were di-
vided into four groups (12 rats in each group): suramin
(300 mg/ml) group; suramin (200 mg/ml) group; suramin
(100 mg/ml) group, and control (saline) group.
Reagents
Suramin was purchased from Cayman Chemical Co., USA.
Rat model
The surgery of laminectomy on rat was operated by the
steps described before [17]. Before the surgery, each rat
was anesthetized using 1 % pentobarbital sodium by intra-
peritoneal injection. Then, we shaved the rat around L1
and L2 and sterilized the exposed skin after the shaving.
After exposing the fascia and the paraspinal muscles by a
midline skin incision, the spinous process and vertebral
plate of the L1 and L2 were removed by a rongeur. Then,
a complete 5 × 2 mm area of the dura mater was exposed.
All rats underwent a total L1 laminectomy.
Local application of drugs
Following satisfactory hemostasis, cotton pads soaked with
suramin in various concentrations of 100, 200, 300 mg/ml,
and saline (9 mg/ml) were administered to the exposed
laminectomy sites for 5 min. The surrounding tissues were
covered by wet gauzes to avoid touching the agent. Then,
the suramin-soaked cotton wool was removed and the
decorticated areas of laminectomy were irrigated with sa-
line to get rid of the remaining suramin immediately. After
the above operations, the wounds were closed in layers.
Macroscopic assessment of epidural fibrosis
After 4 weeks, six rats were randomly picked from each
group for macroscopic evaluation. The surgical sites were
reopened through previous operative incision, and the
epidural scar fibrosis was evaluated under double-blind
trials according to Rydell’s standard [18, 19]: grade 0, little
epidural scar tissue without adherence to the dura mater;
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grade 1, moderate epidural scar tissue with slight
adherence to the dura mater; grade 2, moderate epidural
scar tissue with tight adherence to the dura mater and
dissected with difficulty without disrupting the dura mat-
ter; and grade 3, epidural scar tissue was firmly adherent
to the dura mater and could not be dissected.
Determination of hydroxyproline content in epidural scar
tissue
After macroscopic observation, the rats were euthanized
with a high dose of pentobarbital sodium, and about 5 mg
(wet weight) of scar tissue was got from the decorticated
areas. The samples were lyophilized, grounded, and hydro-
lyzed separately. Then, they were neutralized with 2.5 N
NaOH by using methyl red as the indicator. One milliliter
chloramine-T was added to the hydrolyzed samples as well
as four hydroxyproline standards of four known concentra-
tions. Following 20-min incubation at room temperature,
the hydroxyproline developer was added to the samples
and standards. A spectrophotometer was used to measure
the absorbance of the solution at 558 nm, and the calcula-
tion of the hydroxyproline content per milligram of scar
tissue was based on the standard curve constructed by the
serial concentration of commercial hydroxyproline.
Histological analysis
Six rats were picked randomly from the four groups at
4 weeks postoperatively. Following anesthesia by
pentobarbital sodium, a 4 % paraformaldehyde solution
intracardially perfused was needed for histological
analysis. The entire L1 spine column, including around
tissues, was removed. After 4 days soak by 10 % buffered
formalin, each specimen was decalcified in ethylenedi-
amine tetraacetic acid (EDTA) and glycerol solution for
30 days to decalcify, then embedded in paraffin. The
upright L1 vertebra has made 12 continuous transversal
sections of 4 μm from the highest organizations to the
grass root. From which of them, six odd sections were
stained by means of hematoxylin and eosin (H&E), and
the epidural scar adhesion was assessed through a light
microscope with the magnification of ×40. At a magnifi-
cation of ×400, three fields of the laminectomy sites in
each section, fibroblast density was calculated. The other
six even sections use the method of Trichrome stained
by Masson, and the process of collagen tissue prolifera-
tion was presented through the ×200 magnified light
microscope. Also, Image Pro Plus 6.0 image analysis
software was used to determine the optical density value
of positively stained collagen.
Statistical analysis
All of the statistical analyses were performed by SPSS soft-
ware (version 15.0). The results of data were expressed as
mean ± standard deviation value. For all analyses, P values
<0.05 were considered statistically significant.
Results
The effect of suramin on fibroblast proliferation
To clarify the effect of suramin on fibroblasts prolifera-
tion, we used suramin at concentrations of 0, 200, 400,
and 600 mg/l to treat fibroblasts for 48 h. After the
fibroblasts were treated with four known concentrations
of suramin, the results of the CCK-8 assay revealed sura-
min could inhibit fibroblast proliferation and were
shown in a dose-dependent manner (Fig. 1a).
We further confirmed the effect of suramin on expression
of the cell proliferation markers [20, 21], and the results of
Fig. 1 Suramin inhibited fibroblast proliferation. After treating with
suramin for 48 h at doses of 0, 200, 400, 600 mg/l, CCK-8 assay (a)
and western blot assay of the expression of cell proliferation markers
(cyclinD1, cyclinE, and PCNA) were used to detect cell proliferation
(b). The expression of cyclinD1, cyclinE, and PCNA was decreased in
a dose-dependent manner. The band intensities for cyclinD1, cyclinE,
and PCNA were expressed as a histogram relative to β-actin (c).
*P < 0.05 versus controls
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western blot shown that suramin could decrease the expres-
sions of cyclin D1, cyclin E, and PCNA (Fig. 1b, c). All these
results indicate that suramin could inhibit the proliferation
of the fibroblast in a dose-dependent manner.
Macroscopic evaluation of scar adhesion
The results of macroscopic observation, classified according
to Rydell’s classification, suggested that grade 3 epidural
adhesions existed in all of the control group rats. Grade 0,
1, and 2 were found in the suramin-treated group (Table 1).
Hydroxyproline content analysis
The hydroxyproline contents of each group were shown in
Fig. 2. The hydroxyproline contents in 300 and 200 mg/ml
suramin groups were less than those in 100 mg/ml suramin
group (P < 0.05) and in control group (P < 0.05). The
hydroxyproline content in 300 mg/ml suramin group was
also less than in 200 mg/ml suramin group (P < 0.05).
However, the difference between 100 mg/ml suramin and
control group was not significant (P = 0.088).
Effect of suramin on epidural fibrosis in histological
analysis
In the laminectomy sites of 100 mg/ml suramin and
control group, thick epidural fibrosis with extensive
adherence to dura mater was found (Fig. 3c, d), and a
particularly large number of fibroblasts were found out-
side the dura mater (Fig. 4c, d). In 200 mg/ml suramin
group, less epidural fibrosis was seen and fibroblasts
were decreased around the laminectomy sites compared
with all those in control group (Figs. 3b and 4b). What
is more, little epidural fibrosis was found in the laminec-
tomy sites of 300 mg/ml suramin group and the number
of fibroblasts was markedly reduced (Figs. 3a and 4a).
As shown in Fig. 5a, b, collagen-tissue hyperplasia was
reduced and less epidural fibrosis were found outside the
dura mater compared with those of 100 mg/ml treated
group and control group. Particularly, the collagen-tissue
hyperplasia in 300 mg/ml suramin-treated group was
markedly reduced (Fig. 5a).
Effect of suramin on fibroblasts counting in histological
analysis
As shown in Fig. 6, fibroblasts counting in epidural fibrosis
tissue in the 300 mg/ml suramin group was markedly
decreased compared with the control group (P < 0.05).
Besides, fibroblasts counting in the 200 mg/ml suramin
group was also less than the control group (P < 0.05). How-
ever, the difference between 100 mg/ml suramin group and
control group had no statistical significance (P = 0.15).
Effect of suramin on collagen density in histological
analysis
As shown in Fig. 7, the optical density value of collagen
tissue in the four groups was shown in a dose-dependent
manner. The collagen density was low in the epidural scar
tissue of the suramin-treated groups compared with that
of the control group (P < 0.05).
Discussion
The dense and thick epidural fibrosis that developed after
laminectomy often results in serious negative effects,
which is characterized by severe, chronic, and disabling
nerve radicular or low back pain after laminectomy.
Several factors such as epidural hematoma, fat destruc-
tion, and paraspinal muscular fiber invasion influence the
formation of epidural fibrosis [22]. Moreover, fibroblasts
produce a large amount of collagen and extracellular
matrix components in laminectomy areas, which promote
the formation of epidural fibrosis. In the past few
decades, various biological and synthetic materials were
used to reduce the formation of fibrosis. Besides, some
drugs such as chemotherapy drugs and nonsteroidal
anti-inflammatory drugs were proved to be useful in
preventing the epidural fibrosis [23, 24].
Fig. 2 Hydroxyproline contents in epidural scar tissue in suramin-
treated groups and control group. Hydroxyproline content was
expressed as micrograms per milligrams. *P < 0.05 compares with
that in control group
Table 1 The degree of epidural scar adhesion according to the
Rydell standard
Group Grade
0 1 2 3
Suramin (300 mg/ml) 4 2 0 0
Suramin (200 mg/ml) 3 2 1 0
Suramin (100 mg/ml) 0 0 3 3
Saline (9 mg/ml) 0 0 0 6
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Fig. 4 Image of fibroblast in epidural fibrosis tissue of the laminectomy sites treated with suramin of 300 mg/ml (a), 200 mg/ml (b), 100 mg/ml
(c), and saline (control, d). Note that less fibroblasts were found in the 300 mg/ml suramin group (a) and 200 mg/ml suramin group (b). However,
a large number of fibroblasts were found in 100 mg/ml suramin group (c) and control group (d). The magnification is ×400
Fig. 3 The representative images of the epidural fibrosis issues in each group. Laminectomy sites treated with 100 mg/ml suramin (c) and saline
(control, d) show that dense epidural fibrosis (asterisk) firmly adhering to the dura mater (arrow). Moderate epidural fibrosis (asterisk) slightly adhering
to the dura mater were found in 200 mg/ml suramin group (b). Thin epidural fibrosis (asterisk) with little adherence to the dura mater were found in
300 mg/ml suramin group (a). The spinal cord was represented by “S” and laminectomy defect was represented by “L”. The magnification was ×40
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As an anti-parasitic drug, suramin has a definite effect
in treatment of trypanosomiasis and onchocerciasis by
inhibiting reverse transcriptase. It is also used to treat
selected malignancies, metastatic diseases, and AIDS
[25]. Besides, it is well known that suramin can inhibit the
activity of many growth factors and cytokine receptors
such as TGF-β, PDGF, and bFGF, as well as some inflam-
matory cytokines. Of those factors, TGF-β and PDGF are
especially important on fibroblasts activity in adhesion
formation and wound healing process, which not only
increase the proliferation of fibroblasts but also enhance
the secretion of extracellular matrix components [26].
The study shown that suramin could inhibit fibroblast
proliferation and reduce epidural fibrosis after laminec-
tomy in rats. In vitro, we tested the effect of suramin on
fibroblast proliferation from epidural scar tissues. From
the CCK-8 analysis (Fig. 1a), we found that suramin had
a remarkable inhibition of fibroblast proliferation with a
concentration-dependent manner. Furthermore, western
blot analysis (Fig. 1b, c) shown that suramin could de-
crease the expression of cell proliferation markers such
as cyclin D1, cyclin E, and PCNA. Consistent with the
previous studies, our study shown that different concen-
trations of suramin could inhibit fibroblast proliferation.
In vivo, we investigated the anti-fibrosis effect of sura-
min on preventing the formation of epidural fibrosis.
The concentration of topically applied suramin chosen
was based on the previous studies [12, 27]. Macroscopic
evaluation and histological observation (Figs. 3, 4)
showed that 300 and 200 mg/ml suramin could reduce
epidural fibrosis as well as inhibit fibroblast proliferation
after laminectomy. However, 100 mg/ml failed. More-
over, the Rydell classification in 300 mg/ml suramin
group was mainly defined at grades 0 to 1, which was
much better than those of other groups (Table 1). Be-
sides, the collagen density (Fig. 5) and hydroxyproline
content (Fig. 2) were also significantly decreased in 300
Fig. 5 Histological images of collagen tissue hyperplasia in epidural scar tissue of each group. The collagen tissues in the section stained with Masson shown
blue. There was low density collagen in 300 mg/ml suramin-treated group (a), which was significantly lesser than the other groups. Moreover, the density of
collagen tissue in 200 mg/ml suramin-treated group (b) was also less than the 100 mg/ml suramin-treated group (c) and saline group (d). The magnification
was ×200
Fig. 6 The fibroblast counts in the four groups of epidural scar
tissue. Fibroblast counting was shown as the number per counting
area. *P < 0.05 versus the control group
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and 200 mg/ml suramin group. What is more, all these
parameters indicated that 300 mg/ml suramin had better
effect in reducing epidural fibrosis compared with other
groups.
Based on the previous reports and our study this time,
we could explain schematically the effect of suramin on
reducing epidural fibrosis. Suramin could inhibit the
combination between the multiple cytokines or growth
factors with their receptors. And in the development of
epidural fibrosis, the production of numerous cytokines
or growth factors and subsequent activation of their re-
ceptors were increased. Once the multiple cytokines or
growth factors were inhibited, the number of fibroblast
and the formation of epidural fibrosis of the laminec-
tomy areas accordingly decreased, which accorded with
our present results. However, the toxicity of suramin via
local absorption is still unknown, and some reports
shown that local application of suramin could result
some adverse reactions [28]. Therefore, the surface area
of application should be limited, and the safety margins
determined. What is more, the definite mechanism of
suramin on inhibiting proliferation of fibroblasts and
reducing epidural scar adhesion was still unclear, and
further research should be carried out along this line of
thought.
Conclusions
In summary, our findings firstly demonstrated that sura-
min could inhibit proliferation of fibroblasts and reduce
epidural fibrosis after laminectomy in rats. There were
no wound infection, healing disorder of the skin, and
other side effects in any rat. It might provide a new tar-
get for the treatment of epidural fibrosis. However, the
potential complication, the format used, and the long-
term effects should be kept in mind prior to clinical
application.
Abbreviation
HE: Hematoxylin and eosin
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